miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration.
Chen R, Coleborn E, Bhavsar C, Wang Y, Alim L, Wilkinson AN, Tran MA, Irgam G, Atluri S, Wong K, Shim JJ, Adityan S, Lee JS, Overwijk WW, Steptoe R, Yang D, Wu SY.
Chen R, et al. Among authors: alim l.
Mol Ther Oncolytics. 2023 Sep 13;31:100725. doi: 10.1016/j.omto.2023.09.001. eCollection 2023 Dec 19.
Mol Ther Oncolytics. 2023.
PMID: 37781339
Free PMC article.